FDA’s food safety head resigns over mass layoffs
Jim Jones, the head of the Food and Drug Administration’s (FDA) food division, resigned Monday, citing the mass firings of ...
New Republic9hOpinion
Top Justice Department Official Quits After Trump Order on Biden
On Friday, West Virginia lawmakers introduced a resolution to rename the state’s highest point—Spruce Knob—after the 47th ...
hcinnovationgroup13h
BREAKING: Mass Layoffs Hit CDC, NIH, FDA
At CDC, current staff members say they haven't been told why and still fear that more cuts could be coming. Among staff who ...
WXXI1d
Health agencies lose staff in key areas as Trump firings set in
As the dust settles from the first wave of firings at health agencies, here's how many people got cut, and the impact of the ...
14 States Sue DOGE Alleging Elon Musk Is Acting As An ‘Agent Of Chaos’—Here’s What To Know
Fourteen states led by New Mexico sued the Department of Government Efficiency, or DOGE, on Thursday challenging the alleged ...
Trump administration cuts reach FDA employees in food safety, medical devices and tobacco products
The Trump administration’s effort to slash the size of the federal workforce reached the Food and Drug Administration this ...
FDA Begins Layoffs as Trump Moves to Shrink Federal Workforce
The Trump administration began to fire employees at the Food and Drug Administration Saturday, according to an email notice ...
appliedclinicaltrialsonline5d
Clinical Research, DEI Initiatives Caught in Political Headwinds Amidst Funding Freeze
Recent actions by the FDA and NIH in response to the current political climate have left key stakeholders in clinical trials ...
stockhead5d
Health Check: Despite a ‘biggest ever’ December half, Pro Medicus says it’s just revving up in the US
On the back of US contract wins, home-grown radiology giant Pro Medicus reports a record December half with the promise of ...
manilatimes6d
MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers
MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced the initiation of VALUE, a global, pivotal Phase III trial evaluating ...